FKTQX | MSCVX | FKTQX / MSCVX | |
Total Expense Ratio | 0.48 | 0.78 | 62% |
Annual Report Gross Expense Ratio | 0.48 | 0.79 | 61% |
Fund Existence | 8 years | 12 years | - |
Gain YTD | -2.390 | -2.542 | 94% |
Front Load | N/A | 3% | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.5B | 1.24B | 1,009% |
Annual Yield % from dividends | 3.90 | 3.58 | 109% |
Returns for 1 year | -1.00 | -1.14 | 88% |
Returns for 3 years | 6.43 | 9.85 | 65% |
Returns for 5 years | -3.44 | -0.07 | 5,079% |
Returns for 10 years | N/A | 22.32 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSCX | 49.21 | -0.24 | -0.49% |
BlackRock Health Sciences Opps Inv C | |||
FALIX | 54.93 | -0.63 | -1.13% |
Fidelity Advisor Large Cap I | |||
GBCCX | 14.65 | -0.17 | -1.15% |
Gabelli Dividend Growth C | |||
BUITX | 23.51 | -0.38 | -1.59% |
Buffalo Mid Cap Discovery Inst | |||
EMEAX | 12.37 | -0.23 | -1.83% |
Ashmore Emerging Markets Equity A |